These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. Prospects of induced pluripotent stem cell technology in regenerative medicine. Zhang F; Citra F; Wang DA Tissue Eng Part B Rev; 2011 Apr; 17(2):115-24. PubMed ID: 21210760 [TBL] [Abstract][Full Text] [Related]
67. Stem cells create a therapeutic niche. Dangi-Garimella S Am J Manag Care; 2014 May; 20(8 Spec No.):E7. PubMed ID: 25617926 [No Abstract] [Full Text] [Related]
68. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 3. Social impacts and controversial points of clinical practice guidelines; introduction]. Kimura K; Nagai R Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2284. PubMed ID: 24228413 [No Abstract] [Full Text] [Related]
69. A multi-instrumental approach to identify and purify very small embryonic like stem cells (VSELs) from adult tissues. Ratajczak MZ; Kucia M; Ratajczak J; Zuba-Surma EK Micron; 2009 Apr; 40(3):386-93. PubMed ID: 19028104 [TBL] [Abstract][Full Text] [Related]
71. The 'sweet' spot of cellular pluripotency: protein glycosylation in human pluripotent stem cells and its applications in regenerative medicine. Wang YC; Lin V; Loring JF; Peterson SE Expert Opin Biol Ther; 2015 May; 15(5):679-87. PubMed ID: 25736263 [TBL] [Abstract][Full Text] [Related]
72. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 3. Social impacts and controversial points of clinical practice guidelines; 2) Clinical guidelines and consensus development]. Fukui T Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2301-6. PubMed ID: 24228417 [No Abstract] [Full Text] [Related]
73. Regenerative medicine: the hurdles and hopes. Baptista PM; Atala A Transl Res; 2014 Apr; 163(4):255-8. PubMed ID: 24524876 [No Abstract] [Full Text] [Related]
74. Advances in regenerative medicine. Advances in Regenerative Medicine, 13 June 2008, BioPark, Hertfordshire, UK. Clarke BR Regen Med; 2008 Sep; 3(5):769-70. PubMed ID: 18729801 [No Abstract] [Full Text] [Related]
75. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 3. Social impacts and controversial points of clinical practice guidelines; 4) Guidelines in Japan and in the world]. Urashima M Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2313-8. PubMed ID: 24228419 [No Abstract] [Full Text] [Related]
76. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 3. Social impacts and controversial points of clinical practice guidelines; 3) Impact, evaluation and legal issues of clinical practice guidelines]. Shimbo T Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2307-12. PubMed ID: 24228418 [No Abstract] [Full Text] [Related]
77. [The Cutting-edge of Medicine; CKD and regenerative medicine]. Yokoo T Nihon Naika Gakkai Zasshi; 2015 Mar; 104(3):600-6. PubMed ID: 26571750 [No Abstract] [Full Text] [Related]
78. [108th Scientific Meeting of the Japanese Society of Internal Medicine: symposium: 3. The interaction between kidney and other organs; what should physicians know about it? Introduction]. Kimura K; Yamada A Nihon Naika Gakkai Zasshi; 2011 Sep; 100(9):2529. PubMed ID: 22117346 [No Abstract] [Full Text] [Related]
79. [111th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 1. Immunity and diseases in internal medicine--Frontier of pathophysiology and treatment; Introduction]. Mimori T; Kira J Nihon Naika Gakkai Zasshi; 2014 Sep; 103(9):2098. PubMed ID: 27522757 [No Abstract] [Full Text] [Related]
80. [108th Scientific Meeting of the Japanese Society of Internal Medicine: symposium: 3. The interaction between kidney and other organs; What should physicians know about it? (5) Interaction between kidney and bone]. Akizawa T Nihon Naika Gakkai Zasshi; 2011 Sep; 100(9):2559-63. PubMed ID: 22117351 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]